Abstract
Background Oral 5-aminosalicylic acid (5-ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its th......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
